Drug intelligence / Profile preview

Hibi

Development stage
Unknown
Lead developer
AkzoNobel
Modality
Small Molecules
Administration
Topical
01

Overview

Hibi is a prominent brand of antiseptic and disinfectant products, with **chlorhexidine gluconate** as the primary active ingredient. Originally developed by Imperial Chemical Industries (ICI) in the 1950s and currently marketed by Mölnlycke Health Care, the Hibi range (including Hibiscrub and Hibiclens) is a cornerstone of infection control in clinical settings. It is primarily used for pre-operative skin preparation, surgical hand scrubbing, and general skin disinfection. Chlorhexidine is a bisbiguanide antiseptic that exerts its antimicrobial effect by binding to the negatively charged surfaces of bacterial cell walls and membranes. This binding causes a loss of membrane integrity, leading to the leakage of intracellular contents and, at higher concentrations, the coagulation of cytoplasmic proteins, resulting in cell death. It is effective against a broad spectrum of Gram-positive and Gram-negative bacteria, as well as certain fungi and enveloped viruses, and is valued for its persistent antimicrobial activity on the skin.

Brand names
HibiHibiscrubHibiclensHibitaneHibisolHibiguard
Other names
chlorhexidine gluconate

Beyond the preview

Go deeper on Hibi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hibi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call